CD8A and neoplasm: Therefore, in exosome-related immunotherapy protocols, inhibiting the exosome-related regulatory factors of macrophages affects MHC-I expression on the tumor cell membrane, improving the therapeutic effect of CD8+ T cell infusion, which presents a highly attractive prospect.